Pharmaceutical Exports of Iran in OIC Region and Entering International Markets
Abstract
Background: There are various pharmaceutical companies in Iran with high potential. Due to the lack of business with international markets for exports, Iranian pharmaceutical products are mostly traded in domestic markets. Despite numerous studies on pharmaceutical exports in the literature, the performance of Iran in pharmaceutical exports to the Organization of Islamic Cooperation (OIC), remains yet to be evaluated. The novelty of the present work lies in filling this research gap and helping develop policies to expand pharmaceutical exports of Iran.
Materials and Methods: Analysis of results on the current performance of Iranian pharmaceutical exports indicated groups of factors. The most significant factors were product quality and government policies according to questionnaire survey.
Results: Analysis of results on the current performance of Iranian pharmaceutical exports indicated groups of factors. The most significant factors were product quality and government policies according to questionnaire survey.
Conclusion: It was concluded that supervision regulations of pharmaceutical exports were not developed to motivate the expansion of exports. Supervision and control of Iranian pharmaceutical industries would enhance the quality of pharmaceutical products and strongly contribute to the expansion of pharmaceutical exports. It was also found that the quality improvement of pharmaceutical products was a key factor in increasing pharmaceutical exports to international markets.